Video-Urodynamic Characteristics and Predictors of Switching from Botulinum Neurotoxin a Injection to Augmentation Enterocystoplasty in Spinal Cord Injury Patients
Botulinum neurotoxin type A (BoNT-A) injection and augmentation enterocystoplasty (AE) are alternative and effective management strategies for neurogenic detrusor overactivity (NDO) refractory to pharmacotherapy. A great majority of patients with spinal cord injury (SCI) may, however, prefer BoNT-A...
Main Authors: | Chih-Chieh Lin, Hann-Chorng Kuo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/14/1/47 |
Similar Items
-
Long-term Outcomes of Augmentation Enterocystoplasty with an Ileal Segment in Patients with Spinal Cord Injury
by: Jing-Liang Chen, et al.
Published: (2009-06-01) -
Endoscopic Botulinum Toxin Injection for Refractory Enuresis Based on Urodynamic Assessment
by: Gyoohwan Jung, et al.
Published: (2021-09-01) -
Efficacy of Intravesical Botulinum Toxin A Injection in the Treatment of Refractory Overactive Bladder in Children
by: Yu-Hua Fan, et al.
Published: (2023-03-01) -
Atlas of urodynamics /
by: Blaivas, Jerry G., et al.
Published: (2007) -
Novel Applications of OnabotulinumtoxinA in Lower Urinary Tract Dysfunction
by: Jia-Fong Jhang, et al.
Published: (2018-06-01)